Prenatal Endotoxemia and Placental Drug Transport in The Mouse: Placental Size-Specific Effects
Open Access
- 10 June 2013
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 8 (6) , e65728
Abstract
Lipopolysaccharide (LPS) in high doses inhibits placental multidrug resistance P-glycoprotein (P-gp - Abcb1a/b) and breast cancer resistance protein (BCRP - Abcg2). This potentially impairs fetal protection against harmful factors in the maternal circulation. However, it is unknown whether LPS exposure, at doses that mimic sub-lethal clinical infection, alters placental multidrug resistance. We hypothesized that sub-lethal (fetal) LPS exposure reduces placental P-gp activity. Acute LPS (n = 19;150 µg/kg; ip) or vehicle (n = 19) were given to C57BL/6 mice at E15.5 and E17.5. Placentas and fetal-units were collected 4 and 24 h following injection. Chronic LPS (n = 6; 5 µg/kg/day; ip) or vehicle (n = 5) were administered from E11.5–15.5 and tissues were collected 4 h after final treatment. P-gp activity was assessed by [3H]digoxin accumulation. Placental Abcb1a/b, Abcg2, interleukin-6 (Il-6), Tnf-α, Il-10 and toll-like receptor-4 (Tlr-4) mRNA were measured by qPCR. Maternal plasma IL-6 was determined. At E15.5, maternal IL-6 was elevated 4 h after single (ppIl-6 mRNA was also increased after acute and chronic LPS treatments (pAbcb1a/b and Abcg2 mRNA were unaffected. However, fetal [3H]digoxin accumulation was increased (p3H]digoxin myocardial accumulation was increased (p3H]digoxin accumulation and placental size (p<0.0001). Acute and chronic sub-lethal LPS exposure resulted in a robust inflammatory response in the maternal systemic circulation and placenta. Acute infection decreased placental P-gp activity in a time- and gestational age-dependent manner. Chronic LPS decreased P-gp activity in the maternal myocardium and there was a trend for fetuses with smaller placentas to accumulate more P-gp substrate than their larger counterparts. Collectively, we demonstrate that acute sub-lethal LPS exposure during pregnancy impairs fetal protection against potentially harmful xenobiotics in the maternal circulation.Keywords
This publication has 47 references indexed in Scilit:
- Pro-Inflammatory Cytokine Regulation of P-glycoprotein in the Developing Blood-Brain BarrierPLOS ONE, 2012
- ATP-Binding Cassette Transporter Expression in Human Placenta as a Function of Pregnancy ConditionDrug Metabolism and Disposition, 2011
- Tumor necrosis factor alpha increases P‐glycoprotein expression in a BME‐UV in vitro model of mammary epithelial cellsBiopharmaceutics & Drug Disposition, 2010
- REVIEW ARTICLE: Toll‐Like Receptors at the Maternal–Fetal Interface in Normal Pregnancy and Pregnancy DisordersAmerican Journal of Reproductive Immunology, 2010
- Influence of Intermittent Hypoxia on Myocardial and Hepatic P‐glycoprotein Expression in a Rodent ModelPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2009
- Adaptations in placental nutrient transfer capacity to meet fetal growth demands depend on placental size in miceThe Journal of Physiology, 2008
- Activin A is a critical component of the inflammatory response, and its binding protein, follistatin, reduces mortality in endotoxemiaProceedings of the National Academy of Sciences, 2007
- A new mathematical model for relative quantification in real-time RT-PCRNucleic Acids Research, 2001
- Absence of the mdr1a P-Glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A.Journal of Clinical Investigation, 1995
- The MDR1 gene product, P-glycoprotein, mediates the transport of the cardiac glycoside, digoxinBiochemical and Biophysical Research Communications, 1992